Choriocarcinoma - 25 Studies Found
Recruiting |
: Clinical Database and Biobank of Patients With Gynecologic Neoplasms :
|
Recruiting |
: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors :
|
Completed |
: Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors :
|
Completed |
: Sunitinib in Treating Young Patients With Refractory Solid Tumors :
|
Active, not recruiting |
: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy :
|
Recruiting |
: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors :
|
Completed |
: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment :
|
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Completed |
: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors :
|
Completed |
: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma :
|